Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28141623 | 0.80 | TP53 (0.41) | MEN1ALDH1A1KMT2A | |
| SCHEMBL356352 | 0.79 | CA2 (0.43) | MEN1ALDH1A1KMT2A | |
| SCHEMBL9178677 | 0.79 | CA2 (0.43) | MEN1ALDH1A1KMT2A | |
| SCHEMBL9176403 | 0.79 | CA2 (0.43) | MEN1ALDH1A1KMT2A | |
| SCHEMBL9177001 | 0.79 | CA2 (0.43) | MEN1ALDH1A1KMT2A | |
| SCHEMBL6228290 | 0.77 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL2869288 | 0.76 | GRIA1 (0.33) | MEN1USP2ALDH1A1MAPTKMT2A | |
| SCHEMBL16670350 | 0.73 | — | — | |
| SCHEMBL11142806 | 0.73 | LMNA (0.35) | MEN1USP2ALDH1A1MAPTKMT2A | |
| SCHEMBL6241228 | 0.72 | PPARG (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159605-A1 | HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT | ABION INC. (KR) | 2023-05-25 | — | — | US | claimed |
| EP-4144748-A1 | HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT | Abion Inc. (KR) | 2023-03-08 | — | — | EP | claimed |
| US-5716847-A | PHOSPHATE BUFFER-FREE SOLUTION CONTAINING ZWITTERIONIC AMINE BUFFER; STORAGE STABILITY | Simmons, Maxine Helen (NZ) | 1998-02-10 | — | — | US | claimed |
| CN-117530943-A | Formulations for administration of efluromithine | 奥巴斯治疗股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| US-20230159605-A1 | HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT | ABION INC. (KR) | 2023-05-25 | — | — | US | disclosed |
| EP-4144748-A1 | HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT | Abion Inc. (KR) | 2023-03-08 | — | — | EP | disclosed |
| CN-111433364-A | Metabolic engineering of E.coli for biosynthesis of cannabinoid products | 因美制药公司 | 2020-07-17 | — | — | CN | disclosed |
| CN-109689045-A | Purposes of the topical formulations of cannboid in treatment epidermolysis bollosa and Related connective tissue illness | 因美制药公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-106456662-A | Compositions of pentosan polysulfate for oral administration and methods of use thereof | 奥利金制药公司 | 2017-02-22 | — | — | CN | disclosed |
| EP-0603831-B1 | Stable single liquid reagent for the determination of carbon dioxide in serum | MEDICAL ANALYSIS SYSTEMS INC (US) | 1999-11-10 | — | — | EP | disclosed |
| US-5849166-A | Electrophoresis of nucleic acid fragments | AMERSHAM LIFE SCIENCE, INC. (US) | 1998-12-15 | — | — | US | disclosed |
| US-5830642-A | IN PRESENCE OF A BUFFER | AMERSHAM LIFE SCIENCE, INC. (US) | 1998-11-03 | — | — | US | disclosed |